CATHERINE BUSWELL: Open Payments
NPI 1184657165 · ALLIANCE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,658 in 74 payments from 12 companies in 2025. Trend: 2023 $974 · 2024 $1,068 · 2025 $1,658
Food & beverage: $1,546Education: $111
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $386 |
| Teva Pharmaceuticals USA, Inc. | 10 | $284 |
| Alkermes, Inc. | 12 | $265 |
| Otsuka America Pharmaceutical, Inc. | 6 | $168 |
| ABBVIE INC. | 6 | $130 |
| Janssen Pharmaceuticals, Inc | 5 | $111 |
| Indivior Inc. | 4 | $85 |
| Axsome Therapeutics, Inc. | 3 | $84 |
| E.R. Squibb & Sons, L.L.C. | 5 | $81 |
| Lundbeck LLC | 2 | $31 |
Products named: CAPLYTA, ARISTADA, VRAYLAR, UZEDY, INVEGA, REXULTI, SUBLOCADE, Auvelity.
Industry payments across OH — which companies pay providers there.
